Co-occurrence of TERT promotor mutations with BRAF or NRAS alterations correlates with worse prognosis in melanoma

YI-SHUAN SHEENCHIA-YU CHU2020-10-062020-10-0620200007-0963https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090008674&doi=10.1111%2fbjd.19416&partnerID=40&md5=2a49b1b072cebbcd30881facdb8420a8https://scholars.lib.ntu.edu.tw/handle/123456789/516536Co-occurrence of TERT promotor mutations with BRAF or NRAS alterations correlates with worse prognosis in melanomanote10.1111/bjd.194162-s2.0-85090008674